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(3)1. Current literature highlights
1.1. An array of 1,2,4-triazole methionine aminopeptidase-2
inhibitors
The growth of blood vessels, or angiogenesis, is a key step
in the progression of several diseases, including diabetic
retinopathy, rheumatoid arthritis and cancer. Pathways
that are essential in angiogenesis thus become rational tar-
gets in the search for new therapies for these diseases. One
such target is methionine aminopeptidase type 2 (MetAP2),
an enzyme that has been identiﬁed as the target for fum-
agillin, a potent antiangiogenesis agent. A recent report de-
scribes the discovery of an aniline-1,2,4-triazole inhibitor of
MetAP2, and the synthesis and iteration of a library of
potent inhibitors.1
A high throughput screen against the cobaltous form of
MetAP2 resulted in the identiﬁcation of a triazole inhibitor
(1) that was both potent (Ki = 0.5 nM) and highly selective
over MetAP1 (Ki = 3900 nM). A parallel array of ana-
logues were approached through a synthetic route that
required eight diverse substituted phenylisocyanates that
were converted to mercaptotriazoles and then alkylated
with 12 commercially available alkyl halides. The alkyl-
ation reactions were carried out in a 96-well plate, and a
total of 83 compounds were successfully prepared in yields
varying from 50% to 90% with >95% purity after reverse
phase HPLC puriﬁcation.NN
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After screening the array of compounds against MetAP2 a
number of SAR trends were apparent. An ortho- or para-
methyl substituent or a para-electron-donating group on
the aniline phenyl ring increased potency 10-fold. Thedoi:10.1016/j.comche.2007.10.001
E-mail: nterrett@ensemblediscovery.comS-benzyl substituent was replaced with a 2-thienylmethyl
group and compound (2) was co-crystallised with MetAP2
demonstrating how the contiguous nitrogens on the tri-
azole ring coordinate to cobalt ions in the active site. The
furan derivative (3) was found to be a nanomolar inhibitor
of MetAP2 (Ki = 3 nM) and a potent inhibitor of human
endothelial cell proliferation, as well as blood vessel growth
in an aortic tissue model of angiogenesis.1.2. A solid-phase route to a2b1 integrin inhibitors
The a2b1 integrin is expressed in a variety of cells and can
bind to a number of collagens and laminins. The integrin
has been shown to have a role in a range of cellular func-
tions including haemostasis, thrombosis, cancer metastasis,
wound healing and angiogenesis. As a2b1 is operative in
platelets after their adherence to collagen, this integrin pre-
sents a possible safe target for treating thrombosis. Solid-
phase synthesis has been used to generate a number of small
molecule inhibitors of the a2b1 integrin with potential
applications for anticancer and antithrombotic therapy.2α4β1 antagonist
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been developed as inhibitors of the closely related a4b1 inte-
grin. Against the integrin aIIbb3, 2,3-diaminopropionic
acid (DAP) has been shown to occupy a similar role to
Phe derivatives. This new publication describes the design
and generation of an array of compounds that combine a
prolylsulphonamide fragment with DAP derivatives to give
selective a2b1 inhibitors. The prolyl-DAP derivatives (5)
were prepared on solid support using Wang resin with
two positions on the compounds sequentially varied: the
3-position of DAP, and the prolyl amino group. It was
found that the most potent and selective inhibitors pos-
sessed a urea derivative on DAP with a distal benzyl group,
and an aryl sulphonamide group appropriately substituted
on the prolyl nitrogen. Compounds such as (6) were shown
to be potent integrin a2b1 inhibitors (IC50 = 15 nM against
platelets) and were selective over the related a1b1, a4b1 and
a5b1 integrins.N
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(6)2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
The [Ir(COD)Cl]2/dppe system eﬀectively catalyses the
solid-phase [2 + 2 + 2] cycloaddition of resin-bound
dipropargylamine with alkynes under microwave condi-
tions. The reaction results in high purity of isoindoline
derivatives with moderate yields.3
The use of polymer-supported 2,6-disubstituted-dihydro-
2H-pyridin-3-one, as the ‘polymorphic’ core molecule for
the formal synthesis of the piperidine alkaloid (±)-pro-
sophylline has been presented.4
2.2. Solution-phase synthesis
A convenient single-vessel conversion of primary and sec-
ondary alcohols to primary amines has been reported.
Use of this method results in substantially cleaner crude
products than similar procedures reported in the literature,
and a simple work-up makes this procedure ideal for par-
allel synthesis.5
A combinatorial synthetic route yielding imidazo[1,5-a]-
quinoxalines and pyrazolo[1,5-a]quinoxalines has been
described. The use of 2-ﬂuoroaniline, 1H-imidazole-4-
carboxylic acid and 1H-pyrazole-3-carboxylic acid in theUgi-reaction (U-4CR) followed by a nucleophilic aromatic
substitution (SNAr) aﬀords the imidazo- as well as the
pyrazolo-[1,5-a]quinoxaline moiety in good yield and high
diversity.6
A convenient synthesis of 4H-1,2,4-triazole-3-thiols using
di-2-pyridyl-thionocarbonate as the thiocarbonyl transfer
reagent has been reported. Using two large sets of amine
and hydrazide building-blocks, this method is suitable for
microplate parallel synthesis and produces samples in
screening-ready condition.7
2.3. Scaﬀolds for combinatorial libraries
Desymmetrisation of pyridazine-3,6-diones by the use of
N-benzyl protective groups leads to useful starting materi-
als for building polysubstituted pyridazine libraries in a
regioselective manner.8
2.4. Solid-phase supported reagents
A series of variously-functionalised ﬁrst-, second-, and
third-generation dendrimers have been prepared and linked
via a biphenyl core to a bis-styryl moiety suitable for use as
a crosslinker in polymerisation. Attachment of titanocene
moieties to the ﬁrst-generation system and copolymerisa-
tion with styrene aﬀords polymeric disks that exhibit cata-
lytic properties superior to comparable solution-phase
systems in a multicomponent coupling of chlorosilanes
with Grignards to give bis-allylic silanes.9
2.5. Novel resins, linkers and techniques
Alkylation of secondary sulphonamides by alkyl halides or
alcohols (via the Mitsunobu reaction) is an eﬃcient method
for secondary amine preparation. A ﬂuorous technique has
been proposed to bypass the problem of partial reactions in
parallel chemistry. Thus, o-nitrobenzenesulphonamides
were prepared and alkylated in parallel with various alkyl
halides or alcohols. A reactive ﬂuorous alkyl iodide was
used to trap unreacted sulphonamide allowing for a rapid
and eﬃcient ﬂuorous solid-phase extraction.10
New methodology for the solid-phase synthesis of benzo-
thiazoles, benzimidazoles, and benzoxazoles has been
developed by using a traceless 4-alkoxyaniline linker. The
desired products were released from the polymer support
by an imine-exchange process coupled with air oxidation.
A combinatorial library consisting of 36 members has been
synthesised using this linker.11
‘Click resins’ enable solid phase supported reactions to
work under nearly perfect conditions fulﬁlling the require-
ments of click chemistry. Utilising the formylpyrrolyl-
methyltriazole (FPMT) linker, which is readily available
via copper(I)-catalysed azide-alkyne cycloaddition, a parallel
synthesis of dopaminergic phenylacetylenes has been
achieved. A focused library of 20 test compounds revealing
three points of diversity has been generated by a four-step
SPOS approach including microwave assisted Sonogashira
coupling. GPCR-ligand binding assays indicated excellent
dopamine D3 and D4 receptor binding aﬃnities.12
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A library of new thalidomide analogues containing an
oleﬁn functionality have been synthesised from their aryl
halogenated precursor using a Heck cross coupling reac-
tion. All analogues were tested for their ability to inhibit
the synthesis of the pro-inﬂammatory cytokine Tumour
Necrosis Factor (TNF).13
A novel class of Growth Hormone Secretagogues (GHS),
based on a tetrazole template, has been discovered. In vitro
SAR and in vivo potency within this new class of GHS are
described, and solution and solid phase protocols for the
synthesis of tetrazole based GHS have been developed.14
Methods appropriate for the parallel synthesis of libraries
based on the tricyclic thioxanthen-9-one-10,10-dioxide
scaﬀold have been reported. The novel compounds were
synthesised from previously reported 3-chlorothioxan-
then-9-one-10,10-dioxide and commercially available
3-carboxylic acid thioxanthen-9-one-10,10-dioxide. The
library members were screened for activity in a ﬂuorescence
polarisation assay for inhibitors of BRCT domains of
breast cancer gene 1 and in cell-based secreted alkaline
phosphatase reported replicon system for activity against
hepatitis C virus.15
A library of new compounds derived from inhibitors of his-
tone deacetylases (HDACs) have been synthesised and
their antiproliferative activities towards non small lung
cancer cell line H661 evaluated. Their design is based on
hybrids between indanones to limit conformational mobil-
ity and other known HDAC inhibitors. The synthesis of
these new derivatives was achieved by alkylation of
appropriate indanones to introduce the side chain bearing
a terminal ester group, the latter being a precursor of
hydroxamic acid and aminobenzamide derivatives.16
An erythromycin analogue, 11,12-di-O-iso-butyryl-8,9-
anhydroerythromycin A 6,9-hemiketal, has been found to
be a potential anti-MRSA and anti-VRE agent. The use
of copper catalyzed azide–acetylene cycloaddition, and
click chemistry, readily provided 10 types of triazole ana-
logues in good to nearly quantitative yield and one library
compound exhibited activity against MRSA and VRE bac-
terial strains.17
A versatile parallel synthetic method to obtain three series
of non-cyclic analogues of the ﬁrst drug-like selective
angiotensin II (AT2) receptor agonist has been developed.
In all the three series, AT2 receptor ligands with aﬃnities
in the lower nanomolar range were found, and none of
the analogues exhibited any aﬃnity for the AT1 receptor.
Several compounds were examined in a neurite outgrowth
cell assay and found to exert a high agonistic eﬀect as
deduced from their capacity to induce neurite elongation
in neuronal cells.18
Small constrained non-peptidic molecules consisting of a
polyfunctionalised rigid core, carrying appendages corre-
sponding to arginine and aspartic acid side chains, have
been recently reported to be promising for drug develop-ment. In this work, the 5,6-dihydropyridin-2-one was
envisaged as a scaﬀold to turn into potential integrin
ligands, introducing a carboxylic acid and a basic append-
age. The synthesis and the antiadhesion activity of a small
library of peptidomimetics capable to recognise avb3 and
a5b1 integrins has been reported.19
To identify the pharmacophore of a phosphoramidate pep-
tidomimetic inhibitor of prostate-speciﬁc membrane anti-
gen (PSMA), a small analogue library has been designed
and screened for inhibitory potency. The scope of the
library was designed to test the importance of various
functional groups to the inhibitory potency of the lead
phosphoramidate. The IC50 for the lead phosphoramidate
inhibitor was 35 nM, and the IC50 values for the analogue
library presented a range from 0.86 nM to 4.1 lM.20References
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